Sub-Q Bionics

Company Overview

Snapshot

Founded in February 2025, Sub-Q Bionics operates with 1–10 employees and has raised $1.5 million across one funding round. The company is currently in the R&D product stage, focusing on developing an implantable device for lymphedema patients.

Business overview

Sub-Q Bionics is a Health Tech & Life Sciences company developing an innovative implantable device designed to provide continuous fluid management for lymphedema patients. This technology aims to offer an alternative to daily compression therapy, addressing a critical need in medical treatment and therapeutics. The company operates within the medical devices sector, targeting the healthcare industry with a B2B business model.

Company Intelligence Q&A

What is Sub-Q Bionics' primary focus?

Sub-Q Bionics is focused on developing an implantable device for lymphedema patients to provide continuous fluid management, aiming to replace daily compression therapy.

When was Sub-Q Bionics founded?

Sub-Q Bionics was founded in February 2025.

What is the current product stage of Sub-Q Bionics?

Sub-Q Bionics is currently in the R&D product stage, actively developing its implantable device for lymphedema patients. The company's product development is ongoing as of May 2026.

What sector does Sub-Q Bionics operate in?

Sub-Q Bionics operates in the Health Tech & Life Sciences sector, specifically within Medical Devices and Medical Treatment & Therapeutics.

What is Sub-Q Bionics' business model?

Sub-Q Bionics operates with a B2B business model, targeting the healthcare industry.